Hale - Ginger cat with Best Life. Leading the development of some of the world’s first clinically trialled and registered cannabis medicines for pets, Hale Animal Health is inviting the country’s vets to take a tour of New Zealand’s largest .
Press Release – Hale Animal Health
Hale – Ginger cat with Best Life.
Leading the development of some of the world’s first clinically trialled and registered cannabis medicines for pets, Hale Animal Health is inviting the country’s vets to take a tour of New Zealand’s largest medicinal cannabis facility.
Part-owned by medicinal cannabis company, Helius Therapeutics, Hale Animal Health is set to host veterinarians at its joint headquarters. Those in attendance will hear more about the future of cannabidiol-based (CBD) products for New Zealand’s pets as well as first-hand international insights.
An update will be provided on the extensive R&D work now underway in the quest for Hale’s CBD veterinary-prescribed medicines to achieve approval by the country’s regulator, ACVM (Agricultural Compounds and Veterinary Medicines).
+Undoctored
Tuesday 27 April 2021, 01:42 PM
2 minutes to Read
With vaccinations for Covid-19 top of mind, Kiwi pet owners are making enquiries about whether their four-legged friends should also join the queue, but there’s absolutely no need to worry, says animal specialists and premium New Zealand pet supplement company, Hale Animal Health.
“Globally, there are very few examples of transmission from humans to animals, including to domestic dogs and cats. At the same time, there are no reports or evidence that dogs and cats can transmit the virus to people,” says Managing Director of Hale Animal Health, Leila de Koster.
“With substantial research pointing to the fact that pets do not easily acquire Covid-19, nor seemingly spread it to other animals, nor develop significant disease, the best information confirms that vaccination for pets is not necessary at this point,” says Ms de Koster.